Efficacy of Using Voiding Time as a Uroflow Parameter for Detecting Urinary Obstruction in Men with Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20250707009

Enrollment

170

Registered

2025-07-07

Start date

2023-05-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia (BPH), Lower Urinary Tract Symptoms (LUTS) caused by BPH. Benign Prostatic Hyperplasia (BPH) Lower Urinary Tract Symptoms (LUTS) Urinary Obstruction Voiding Time Uroflowmetry Urinary Flow Rate Prostate Urinary Retention Urinary Tract Diseases Prostate Diseases Urinary Tract Obstruction

Interventions

symptomatic patients aged 45 years or older who presented with bothersome LUTS due to BPH, with an IPSS of 8 or higher (these patients experienced significant urinary symptoms that impacted their qual

Diagnostic,Diagnostic

Case Group,Control Group

Eligibility

Sex/Gender

Male

Age

45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Adult males aged 45 years or older. 2. Diagnosis of Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH). 3. Informed consent given by the patient to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients unable to comprehend the study or comply with it 2. Patients with LUTS due to conditions other than BPH Patients with a history of concomitant drug treatment with Androgens, 3. Anti-androgens, Diuretics, Cholinergics, or Anti-cholinergics within the past 3 months 4. Patients with evidence of symptomatic Urinary Tract Infections, Chronic inflammation, or severe Renal Impairment (Serum Creatinine more than 2.0 mg/dl). 5. Patients with concurrent Prostate Malignancy or a history of cancer within the preceding 5 years.

Design outcomes

Primary

Measure	Time frame
Sensitivity of Voiding Time (VT) Baseline (Enrollment Visit), Follow-Up Visit 1 (Day 7), Follow-Up Visit 2 (Day 14) Seconds	—

Secondary

Measure	Time frame
Comparison of Voiding Time in patients with different levels of LUTS severity Baseline (Enrollment Visit), Follow-Up Visit 1 (Day 7), Follow-Up Visit 2 (Day 14) Seconds,Sensitivity, specificity, Positive Predictive Value (PPV), Negative Predictive Value (NPV), and diagnostic accuracy of Voiding Time Baseline (Enrollment Visit), Follow-Up Visit 1 (Day 7), Follow-Up Visit 2 (Day 14) N/A	—

Countries

India

Contacts

Public ContactHimanshu Agrawal

UCMS and GTB Hospital, Delhi

himagr1987@gmail.com09999472790

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026